Table 2.
Baseline Clinical and Biochemical Data in the Study Subjects
| Group A (−T, −E) | Group B (−T, +E) | Group C (+T, −E) | Group D (+T, +E) | p | |
| n | 15 | 15 | 15 | 14 | |
| Age (yr) | 71 (55, 75) | 67 (58, 72) | 69 (67, 73) | 68 (54, 76) | 0.603 |
| Height (m) | 1.75 (1.74, 1.79) | 1.78 (1.69, 1.83) | 1.78 (1.76, 1.84) | 1.79 (1.74, 1.82) | 0.701 |
| Weight (kg) | 84.6 (78.5, 98.7) | 86.4 (71.2, 99.6) | 88.2 (81.9, 93.5) | 87.3 (82.6, 95.4) | 0.879 |
| Calcium (mg/dl) | 9.4 (9.1, 9.6) | 9.6 (9.2, 9.8) | 9.4 (9.2, 9.6) | 9.3 (9.2, 9.7) | 0.467 |
| Phosphorus (mg/dl) | 3.4 (3.3, 3.5) | 3.5 (3.3, 3.7) | 3.2 (3.0, 3.5) | 3.2 (2.8, 3.4) | 0.128 |
| Bone resorption markers | |||||
| Serum CTX (ng/ml) | 0.53 (0.36, 0.67) | 0.45 (0.38, 0.73) | 0.51 (0.30, 0.60) | 0.50 (0.33, 0.65) | 0.940 |
| Serum TRACP5b (U/liter) | 3.0 (2.6, 3.8) | 2.6 (2.1, 3.3) | 2.8 (2.5, 3.8) | 2.9 (2.6, 3.0) | 0.502 |
| Urine NTX (nmol/d)* | 268 (171, 333) | 290 (242, 329) | 274 (224, 357) | 272 (250, 410) | 0.644 |
| Bone formation marker | |||||
| PINP (μg/liter) | 36 (30, 50) | 40 (32, 51) | 39 (31, 47) | 36 (27, 53) | 0.880 |
p value is for comparison across groups by ANOVA. Data are median (IQR).
* Log2 was used.